The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Inflammation significantly contributes to the progression of chronic kidney disease (CKD). Inflammasome-dependent cytokines, such as IL-1β and IL-18, play a role in CKD, but their regulation during renal injury is unknown. Here, we analyzed the processing of caspase-1, IL-1β, and IL-18 after unilateral ureteral obstruction (UUO) in mice, which suggested activation of the Nlrp3 inflammasome during renal injury. Compared with wild-type mice, Nlrp3(-/-) mice had less tubular injury, inflammation, and fibrosis after UUO, associated with a reduction in caspase-1 activation and maturation of IL-1β and IL-18; these data confirm that the Nlrp3 inflammasome upregulates these cytokines in the kidney during injury. Bone marrow chimeras revealed that Nlrp3 mediates the injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments. In tissue from human renal biopsies, a wide variety of nondiabetic kidney diseases exhibited increased expression of NLRP3 mRNA, which correlated with renal function. Taken together, these results strongly support a role for NLRP3 in renal injury and identify the inflammasome as a possible therapeutic target in the treatment of patients with progressive CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Cited by
Items 501–600 of 603
Vijiyakumar, N., & Prince, S. E. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2026.2656926 · Cited by 4
Wang, Y., Deng, X., Yang, Z., & Wu, H. (2023) · Medicine · doi:10.1097/md.0000000000034713 · Cited by 3
Zheng, L., Mei, W., Zhou, J., Wei, X., Huang, Z., Lin, X., Zhang, L., Liu, W., Wu, Q., Li, J., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12430 · Cited by 3
Cilastatin Attenuates Acute Kidney Injury and Reduces Mortality in a Rat Model of Sepsis
González-Nicolás, M. Á., Humanes, B., Herrero, R., Arenillas, M., López, B., Ferruelo, A., Lorente, J. A., & Lázaro, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167927 · Cited by 3
Tian, B., Hua, Z., Wang, Z., & Wang, J. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01836-y · Cited by 3
RetractedYakout, S. M., Alfadul, H., Ansari, M. G. A., Khattak, M. N. K., & Al‐Daghri, N. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216377 · Cited by 3
“Several studies have reported that VD can inhibit NLRP3 inflammasome activation and subsequent release of IL–1 β and IL– 18 [47,48].”
BackgroundRole of Proteinuria in the Progression of Renal Disease
Abbate, M., Macconi, D., Remuzzi, G., & Zoja, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00087-2 · Cited by 3
Malignant Nephrosclerosis in a Patient with Familial Mediterranean Fever
Yamanouchi, M., Ubara, Y., Imafuku, A., Kawada, M., Mise, K., Sumida, K., Hiramatsu, R., Hasegawa, E., Hayami, N., Suwabe, T., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.4937 · Cited by 3
Cao, Q., Foley, M., Gill, A. J., Chou, A. S. Y., Chen, X., & Pollock, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313127 · Cited by 2
Tan, H. Z., Li, F., Cui, Y. C., Li, Z., Yan, S., & Deng, Q. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1598151 · Cited by 2
“NLRP3 − / − mice exhibited less tubular injury, in fl ammation, and fi brosis after UUO than wild-type mice (Vilaysane et al., 2010).”
Bano, R., Clouston, S., Mann, F. D., Khan, B. A., Carr, M. A., Hedayati, S. S., Luft, B. J., & Koraishy, F. M. (2025) · Kidney360 · doi:10.34067/kid.0000000880 · Cited by 2
Komori, S., Komada, T., Matsumura, T., Karasawa, T., Miura, Y., Baatarjav, C., Gunji, Y., Aizawa, H., Mizushina, Y., Fukushima, N., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.08.010 · Cited by 2
Wu, T.-K., Hsieh, Y., Hung, T., Chiou, H., Shih, H.-Y., Ting, Y.-H., Pan, Y., Liu, C., & Kao, S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178367 · Cited by 2
de Oliveira, C. B. L., Guaraná, W. L., Vajgel, G., Júnior, B. M. D. S., de Lima, C. A. D., Araújo, S. D. A., Souto, F. O., Costa, D. M. D. N., Valente, L. M., & Sandrin‐Garcia, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010043 · Cited by 2
“…of NLRP3 activation intensity as a prognostic marker in active LN. Studies using animal models have demonstrated the contribution of NLRP3 inflammasome activation to kidney inflammation, tubulointerstitial fibrosis, glomerulosclerosis, and progression of chronic kidney disease (CKD) [12,34].”
Lahane, G. P., Bhat, A., & Dhar, A. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117894 · Cited by 2
Salt and chronic kidney disease
Murray, J., Marsman, R. F. J., Engberink, R. O., & Vogt, L. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01076-y · Cited by 4
“Kidney-biopsy samples from patients with DKD or CKD showed increased expression of NLRP3 mRNA, which correlated with lower eGFR 285,286 .”
Wang, W., Li, J., Zhong, Y., Chen, J., Wu, L., Wan, L., Huang, X.-R., Ye, Z., Yu, X., & Lan, H.-Y. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.131452 · Cited by 2
“…inflammasome is crucial for the host defense against pathogen invasion [2] and plays a pathogenic role in various inflammatory diseases, such as type 2 diabetes and Alzheimer’s disease [3], acute kidney injury (AKI) and chronic kidney disease (CKD) including diabetic kidney disease (DKD) [4-6].”
Self-citationMore, S. A., Patil, A., Joshi, M., Dhokne, P., Nimbarte, V. D., & Mulay, S. R. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12522-2 · Cited by 2
“CKD models represented included UUO [ 22– 24], 5/6 subtotal nephrectomy [ 25–28], adenine-induced nephropathy [29], DKD [ 30 , 31 ], oxalate nephropathy [ 32], cisplatin-induced renal injury [33 ], aldosterone-mediated renal damage [ 34 , 35 ], albumin over-load [ 36 ], chronic intermittent hypoxia…”
InfluentialZhuang, Y., Jia, Z., Hu, C., Ding, G., Zhang, X., Zhang, Y., Yang, G., Rohatgi, R., Huang, S., He, J. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10257 · Cited by 2
“NS, Nephrotic syndrome; NLRP3, NOD-like receptor family, pyrin domain containing 3; NLR, NOD-like receptor; PYHIN, pyrin and HIN200 domaincontaining protein; CKD, chronic kidney disease; COX-2, cyclooxygenase-2; PGE2, prostaglandin E2; mPGES-1, membrane associated PGE synthase-1; TAL, thick ascending limb; NKCC, Na-K-…”
BackgroundJohns, T. S., Estrella, M. M., Hébert, J. R., Franceschini, N., Larson, J. C., Boulware, L. E., Snetselaar, L., Golestaneh, L., Shadyab, A. H., Shivappa, N., et al. (2025) · Kidney360 · doi:10.34067/kid.0000000801 · Cited by 2
Gao, P., He, F.-F., Tang, H., Lei, C., Chen, S., Meng, X., Su, H., & Zhang, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1213892 · Cited by 2
Anandh, U., & Saxena, A. (2024) · Journal of Renal Nutrition and Metabolism · doi:10.4103/jrnm.jrnm_1_23 · Cited by 2
Pyroptosis and sepsis-associated acute kidney injury.
Xiao, C., & Li, X. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.240233 · Cited by 1
“…repeat and pyrin domain-containing 废物积聚等 [18-19] 。无论病因如何,细胞死亡和炎症是 SA-AKI 发病机制中重要的特征性事件。越来越多的 证据表明细胞焦亡参与 SA-AKI ,其中对肾实质细胞 中焦亡的探索才刚刚开始:有研究者 [20] 在人体肾活检 组织中检测到 NLRP3 mRNA 的表达增加,且与肾功 能相关;肾小管上皮细胞发生焦亡后释放的高迁移 率族蛋白 1(high mobility group box 1 , HMGB1) 促进 了白细胞的活化、募集和肾脏炎症效应 [21] ;黑素瘤缺 乏因子 2(absent…”
Xu, Q., Li, J., Wan, X., Wang, G., Wu, J., Chang, X., Yan, F., Li, L., & Han, B. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.105053 · Cited by 1
Serum RAC1 as a potential biomarker in the early stages of diabetic kidney disease
Yao, F., Mo, X., Wang, N., Ma, Q., Fu, R., Sun, Y., Yang, T., Raj, J. B., Zhou, X., & Ying, C. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01983-3 · Cited by 1
Mohammed, N. A., Osman, A., Taher, E. S., Ibrahim, M. M., Badr, B. M., Eraky, S. M., Ali, F. E. M., & Mohamed, E. A. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05518-w · Cited by 1
Buckner, T. (2016) · Lincoln (University of Nebraska) · Cited by 1
Inflammasome Activation by Paramyxoviruses
Shil, N. K., Pokharel, S. M., & Bose, S. (2017) · Current Clinical Microbiology Reports · doi:10.1007/s40588-017-0070-x · Cited by 1
Current Opinion in the Treatment of Diabetic Nephropathy
Chen, X., Huang, C., & Pollock, C. A. (2015) · Nephrology - Open Journal · doi:10.17140/npoj-1-104 · Cited by 1
Experience with canakinumab in a patient with gout and IgA nephropathy
Ilyinykh, E. V., & Елисеев, М. С. (2019) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2019-3-71-75 · Cited by 1
“Более того, учитывая имеющиеся данные об активации почечного NLRP3 при ХБП [18, 19], можно предположить, что ингибиция ИЛ1β могла способствовать и уменьшению прогрессирования ХБП (у нашего пациента наблюдалось стойкое увеличение СКФ после введения канакинумаба).”
Nonatherosclerotic Vascular Abnormalities Associated with Chronic Kidney Disease
Mohandas, R., Chamarthi, G., & Segal, M. S. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.04.012 · Cited by 2
Cytokines, Chemokines, Inflammasomes, Myokines and Complement-Related Factors in Acute Kidney Injury
Peñata, E. Z., Fiorillo-Moreno, O., Meza-Torres, C., & Quiroz, E. N. (2023) · Springer eBooks · doi:10.1007/978-3-031-36789-2_5 · Cited by 1
Anandh, U., & Saxena, A. (2023) · Journal of Renal Nutrition and Metabolism · doi:10.4103/jrnm.jrnm_6_23 · Cited by 1
López-Rodríguez, E., & Ochs, M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0158le · Cited by 1
Thomas, J., Huuskes, B. M., Sobey, C. G., Drummond, G. R., & Vinh, A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4055073 · Cited by 1
Guo, T., Jiang, H., Tang, F., Ma, R., Wang, Z., Chen, J., Zhuang, C., Jiang, J., Mou, Y., & Yu, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2344975/v1 · Cited by 1
Sung, R. (2015) · Scholarship@Western (Western University) · Cited by 1
Die Rolle des NLRP3-Inflammasoms bei Immunkomplex-vermittelten Glomerulonephritiden
Andersen, K. (2015) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17927
Chen, Y., Chen, C., Yan, W., Ge, H. M., & Kong, L. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.03.013
Braga, T. T. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24092014-184133 · Cited by 1
Renin-Dependent Hypertension in Mice Requires the NLRP3-
Nussberger, J., Ives, A., Bagnoud, N., Shäefer, S., & Tschopp, J. (2014)
Self-citationTrials and Tribulations of New Agents, Novel Biomarkers, and Retarding Renal Progression
Toto, R. D., Remuzzi, G., Maschio, G., Zucchelli, P., Himmelmann, A., Bannister, K. M., Landais, P., Shahinfar, S., & Lau, J. (2011)
Characterization of NLRP3 in the Maintenance of Cardiac Tissue Homeostasis
Bracey, N. A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25279
injuryinflammasome activation and renal tubular Mitochondrial dysfunction confers albumin-induced
Wang, R., Jia, Z., Huang, S., Zhang, A., Zhuang, Y., & Hu, C. (2016)
Tubular Mechanisms in Proteinuria
Verma, S. K., & Molitoris, B. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-43359-2_3
A Non-Canonical Function for NLRP3 and AIM2 in Kidney Diseases
Chung, H. J. (2017) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/24925
Moreira, G. C. D. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-19062017-155418
Papel da endotelina-1 na ativação do NLRP3 no tecido muscular liso do corpo cavernoso
Fais, R. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-21072016-161830
Zambom, F. F. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-06112018-133531 · Cited by 1
Fais, R. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-05062020-084655 · Cited by 1
Clinical biobanking and the distinguishing risk of progressive chronic kidney disease study
Owens, E. P. (2021) · The University of Queensland · doi:10.14264/9afbe89
de Toro, C. L., & del Valle, I. D. (2013)
Untersuchungen zum Inflammasom bei proinflammatorischem Zellstress des Muskels in vitro und in vivo
Bertram, I. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8709
Canonical and noncanonical Inflammasomes in kidney disease
Andrade-Silva, M., Watanabe, I. K. M., & Câmara, N. O. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00004-9
A Recombinant Lipl21 Protein Vaccine from Five Leptospira interrogans Strains Against
Thuỷ, V. T. B. (2020) · Approaches in Poultry Dairy & Veterinary Sciences · doi:10.31031/apdv.2020.08.000676
“Therefore, the activate of the immune response including inflammasome activation [19,20], cytokines production [21], and autoimmune reactions [22], can”
BackgroundSabra, M. S., Hemida, F. K., & Allam, E. A. H. (2023) · Research Square · doi:10.21203/rs.3.rs-2556098/v1
Sabra, M. S., Hemida, F. K., & Allam, E. A. H. (2023) · Research Square · doi:10.21203/rs.3.rs-2594505/v1
Sabra, M. S., Hemida, F. K., & Allam, E. A. H. (2023) · Research Square · doi:10.21203/rs.3.rs-2556098/v2
Zambom, F. F. F. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-12042023-143020
Garg, A. X., Cuerden, M. S., Cata, J. P., Chan, M. T. V., Devereaux, P. J., Fleischmann, E., Grande, A. M., Kabon, B., Landoni, G., Maziak, D. E., et al. (2023) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581231185427 · Cited by 1
Insights into protein-bound uremic toxins in proximal tubule cell senescence and kidney fibrosis
Yang, Y. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1996
Salinomycin attenuates kidney fibrosis and inflammation in mice with unilateral ureteral obstruction
Chen, K., Hsu, H., Yang, H., Ko, Y.-C., & Hung, C. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151130
Suandika, M., Handayani, R. N., & Muti, R. T. (2025) · BIO Web of Conferences · doi:10.1051/bioconf/202515201002
“In innate immunity, the alteration is mainly focused in pattern recognition receptor dysfunction [13], [14].”
InfluentialResearch on the Correlation between NLRP3 Inflammasome and Idiopathic Membranous Nephropathy
张, 宝. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.42255
Zheng, R., Chen, J., Wang, Q., Lyu, J., Deng, M., Han, J., Tan, Z., Yuan, L., & Bai, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-7498649/v1 · Cited by 1
Gupta, S., Erram, V., Ghosh, A., Kulkarni, O. P., Araya, H., Fujimoto, Y., & Begum, A. S. (2025) · ChemMedChem · doi:10.1002/cmdc.202500501
Recent advances in bioinspired polymeric nanofiber for the treatment of inflammatory diseases
Sahu, G., Maurya, M., Pandey, H., & Mishra, S. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27745-0.00011-9
Zhou, X., Ji, S., Chen, L., Liu, X., Deng, Y., You, Y., Wang, M., He, Q., Peng, B., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26082635
Roger, E., Chadjichristos, C. E., Kavvadas, P., Price, G. W., Cliff, C. L., Hadjadj, S., Renciot, J., Squires, P. E., & Hills, C. E. (2024) · Figshare · doi:10.6084/m9.figshare.24217626
Roger, E., Chadjichristos, C. E., Kavvadas, P., Price, G. W., Cliff, C. L., Hadjadj, S., Renciot, J., Squires, P. E., & Hills, C. E. (2023) · Figshare · doi:10.6084/m9.figshare.24217361
Roger, E., Chadjichristos, C. E., Kavvadas, P., Price, G. W., Cliff, C. L., Hadjadj, S., Renciot, J., Squires, P. E., & Hills, C. E. (2024) · Figshare · doi:10.6084/m9.figshare.26620552
Zhou, X., Ji, S., Chen, L., Liu, X., Deng, Y., You, Y., Wang, M., He, Q., Peng, B., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26082689
Cell Death Regulates Injury and Inflammation During Renal Allograft Transplantation
Lau, A. N. (2014) · Scholarship@Western (Western University)
Tang, Y. Y., Gao, Y. C., Liu, T., Wu, J., Wei, L. B., & Gao, J. R. (2026) · Gene · doi:10.1016/j.gene.2026.150029
Garg, V., Kundu, S., Ambujakshan, A., Sohkhia, W., Choudhury, C. S., Verma, S., Mugale, M. N., & Sahu, B. D. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05177-0
“In sepsis, the inflammatory mediators, pathogen-associated molecular patterns, and damage-associated molecular patterns can trigger sepsis-induced organ injury (Vilaysane et al. 2010).”
Cell death in kidney transplantation: Mechanisms and therapeutic perspectives
Zhang, Z., Wang, M., & Cai, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119236
L’angiogénine : un nouveau médiateur de la réponse au stress du Réticulum Endoplasmique
Mami, I. (2015) · theses.fr (ABES) · doi:10.70675/6afe719dz49e3z4195z9936zf9365babca2e
Rôle de la Connexine 43 dans les maladies rénales tubulaires expérimentales
Roger, E. (2024) · theses.fr (ABES) · doi:10.70675/20c51ec5z7148z4d11z8b56zfa9a06604ce4
Ischémie-reperfusion rénale : dépistage précoce de lésions rénales et stratégies de néphroprotection
Schleef, M. (2023) · theses.fr (ABES) · doi:10.70675/271c8727z9c7bz4b64z9cc9z650c991c2bec
Alwan, N. H., & Faraj, H. R. (2026) · Urologia Journal · doi:10.1177/03915603261448982
Effects of chronic jetlag on high-fat and high-fructose diet induced renal injury in mice
Xing, L., Xie, J., Shi, Y., Zheng, R., Zhang, T., Li, X., Zhou, Z., & Zhang, D. (2026) · Scientific Reports · doi:10.1038/s41598-026-54538-5
“Moreover, NLRP3 downstream cytokines IL-1β and IL-18 not only promote immune cell recruitment but also drive epithelial-to-mesenchymal transition 24,66,67 .”
Colchicine attenuates kidney injury by modulating the NLRP3 inflammasome pathway
Kim, G. Y., Heo, G. Y., Nam, B. Y., Cho, Y., Yu, J. W., Park, C. H., Kim, H. W., Park, J. T., Yoo, T., Kang, S. M., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01511-7
“In this study, we used renal tubular epithelial cells (RTECs) as accumulating evidence suggests that NLRP3 inflammasome activation in tubular epithelial cells contributes significantly to CKD progression (Mulay 2019; Vilaysane et al. 2010).”
Kim, M., An, S., Ryu, H., Sun, C., An, H. Y., Ryu, G., Kim, J., Kim, Y., Kim, S. W., Kim, Y. H., et al. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001092
GATA6 marks fibrosis-associated stromal cells rather than repair macrophages in kidney disease
Belay, S. G., Elias, E. E., Lau, A. N., Andonegui, G., Chapman, K., Chun, J., & Muruve, D. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-61940-6
Self-citationPhongphithakchai, A., Pattaranggoon, N. C., Wongna, K., Netphakdee, R., Tedasen, A., Jansakun, C., Klangbud, W. K., Thanasai, J., Kawakami, F., & Chatatikun, M. (2026) · Antioxidants · doi:10.3390/antiox15080915
“Activation of this pathway promotes maturation of IL-1 β and IL-18 and further amplifies renal inflammation [23].”
InfluentialDual Roles of Free Fatty Acids in Gout Pathogenesis: Inflammatory Drivers and Metabolic Mediators
Lin, N., & Shao, C. (2026) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70799
“Chronic inflammation further stimulates fibroblast activation, marked by α-smooth muscle actin (α-SMA) upregulation and extracellular matrix (ECM) deposition (e.g., collagen I/III), driving tubulointerstitial fibrosis [60, 61].”
Hsu, H.-C., Shih, L., Hou, Y., & Lu, K. (2026) · Biomolecules · doi:10.3390/biom16081155
“…and sympathetic overactivity are amplified in the interstitium by chymase-positive mast cells, which generate angiotensin II locally and independently of ACE (Section 3.2.2), while lipid-laden tubular cells recruit macrophages and activate NLRP3 inflammasome and NF-κ B signalling [66,75,95,96].”
InfluentialZhang, Y., Cheng, J., Liao, X., He, X., Zou, S., Zeng, J., Xiong, Y., Yuan, Q., Xie, Y., Huang, L., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01585-3
NLRP3 Deficiency Enhances Neutrophil Motility and Phagocytic Function in the Inflamed Kidney
Yang, H., Park, K.-M., Lim, K.-Y., & Hyun, Y. (2026) · Immune Network · doi:10.4110/in.2026.26.e32
“The NLRP3 inflammasome promotes inflammatory tissue injury mainly through the caspase-1–IL-1 β pathway, which has been implicated in tubular epithelial cell injury and the progression of kidney inflammation (27,28).”
Vijverman, L., Maddalena, T., Delrue, C., & Speeckaert, M. M. (2026) · Biomedicines · doi:10.3390/biomedicines14102143
“Experimental blockade of the NLRP3 pathway has reduced chronic renal inflammation and kidney fibrosis in kidney disease, underscoring the importance of the gut–kidney axis [77].”
Donath-Miklos, I., Știrbu, O., Popețiu, R. O., Crişan, A. S., Vulciu, P. A., Coman, R. A., Avram, C. R., Roman, D. R., Bugari, R. A., Zdremtan, D., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16193084
T‐Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease
Li, Q., Guan, J., Song, Y., Yang, H., Li, G., Zhao, X., Liu, J. H., Liu, B., Tan, Y., 周洪澜, et al. (2026) · Advanced Science · doi:10.1002/advs.78008
“Injured TECs and damaged renal tissue release or expose DAMPs, including extracellular ATP, uric acid-related crystal signals, and mitochondrial DNA, which can activate NLRP3 and promote caspase-1-dependent maturation of IL-1 β and IL-18 in renal injury [ 115, 116 ].”
Abelmoschus manihot in Chronic Kidney Disease: Evidence-Based Therapeutics and Mechanistic Insights
Sun, S., Qiao, L., Zhao, J., Tang, H., Luo, Y., Tao, Y., 陈崇, & Sun, W. (2026) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2026.151723
Gairola, S., Bhatta, A., Mishra, T., & Kaundal, R. K. (2026) · Phytotherapy Research · doi:10.1002/ptr.70470
Bhattarai, D., Nwaduru, C. E., Cardoso, R. P., Pollard, S. H., Buff, M. A., Fenlon, M. R., Selim, M. A., & Zimmerman, M. A. (2026) · Life · doi:10.3390/life16111807
Bueno, L. F. R., Próspero, N. D. G. O., Alves, E. B., Ciscato, P. F., Cotta, M. L. D. A., & Ruivo, G. F. (2026) · Research Society and Development · doi:10.33448/rsd-v15i11.51974
Majnooni, M. B., Naseri, M., Moghadamnia, M., Salehi, A., Rahmani, Y., & Ghanadian, S. M. (2026) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_429_26
Metadata
- Authors
- Vilaysane, A., Chun, J., Seamone, M. E., Wang, W., Chin, R., Hirota, S., Li, Y., Clark, S. A., Tschopp, J., Trpkov, K., Hemmelgarn, B. R., Beck, P. L., & Muruve, D. A.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Vilaysane, Akosua
- Chun, Justin
- Seamone, Mark E.
- Wang, Wenjie
- Chin, Rick
- Hirota, Simon
- Li, Yan
- Clark, Sharon A.
- Hemmelgarn, Brenda R.
- Beck, Paul L.
- Muruve, Daniel A.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-10
- Volume
- 21
- Issue
- 10
- Pages
- 1732-1744
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3013544
- OpenAlex
- W2111994713
- Cited by
- 587
- References
- 44
- Citations by year
- 2026: 30 · 2025: 44 · 2024: 48 · 2023: 40 · 2022: 50 · 2021: 42 · 2020: 43 · 2019: 42 · 2018: 46 · 2017: 36 · 2016: 44 · 2015: 29 · 2014: 36 · 2013: 26 · 2012: 16
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- NLRP3 inflammasome, chronic kidney disease, renal inflammation, caspase-1, IL-1β, IL-18, unilateral ureteral obstruction, renal tubular injury, renal fibrosis, non-diabetic kidney disease, therapeutic target
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cells, Cultured, Fibrosis, Humans, Kidney, Male, Mice, Inbred C57BL, Nephritis, RNA, Messenger, Ureteral Obstruction, Mice, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.